Stocks and Investing Stocks and Investing
Tue, August 13, 2024
Mon, August 12, 2024

Mayank Mamtani Reiterated (ARWR) at Strong Buy and Held Target at $55 on, Aug 12th, 2024


Published on 2024-10-28 13:33:20 - WOPRAI
  Print publication without navigation


Mayank Mamtani of B. Riley Securities, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $55 on, Aug 12th, 2024.

Mayank has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Mayank's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


These are the ratings of the 3 analyists that currently disagree with Mayank


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $60 on, Tuesday, July 23rd, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Wednesday, July 17th, 2024
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, June 20th, 2024